Pyxis Oncology Successfully Completes Acquisition of Apexigen

Go back to Pyxis Oncology Successfully Completes Acquisition of Apexigen
(NASDAQ: PYXS) Delayed: 2.13 --0 (-0%)
Previous Close $2.13    52 Week High
Open $2.13    52 Week Low
Day High $2.13    P/E N/A 
Day Low $2.13    EPS
Volume 640